3rd Annual Neuroscience Innovation Forum

Published on 12 January 2020
3RD ANNUAL NEUROSCIENCE INNOVATION FORUM feature image

About

Sachs Associates are pleased to announce the 3rd Annual Neuroscience Innovation Forum (NIF) for business development and licensing and Investment in Therapeutics and Technology will take place a day before the JP Morgan meeting at The Marines’ Memorial Club, San Francisco on 12 January 2020.

The agenda

Sach 2nd Neuroscience Innovation Forum image 1The NIF agenda covers biopartnering for central nervous system disorders, with industry keynotes and panels on Alzheimer’s disease, Parkinson’s disease, neuropsychiatry and pain management. There are also panels on innovation in neurotech covering banking, devices, diagnostics and software.

The event targets buy- and sell-side analysts from investment banks and funds and partnering executives from pharma, biotech and medtech companies. We expect over 250 delegates and 30+ ​company presentations by established listed, private and emerging companies.

There will be networking opportunities available via an online one-to-one meeting system with dedicated meeting facilities to make the event more transactional.

Reserve your ticket now

We have secured 10% discount for our subscribers.
During registration, simply choose ‘Edison’ under ‘Are you a client/member of one of our partners?

Confirmed keynote speakers

  • Harry Tracy, President, NI Research – 2020 Vision: Neurotherapeutics in the New Decade.
  • Jonathan Javitt, Founder, Chairman & CEO, NeuroRx – NMDA, Glx, and Unlocking the Mysteries of Suicidal Depression & PTSD.

Plenary and therapeutic sessions

Confirmed speakers and chairs

  • State of the industry roundtable
  • Biopartnering and dealmaking panel
  • Advances in Alzheimer’s and other cognitive disorders panel
  • Progress in neuropsychiatry and pain management panel
  • Early-stage innovation panel
  • New Approaches to Parkinson’s and other movement disorders panel
  • Rare and orphan diseases panel
  • Current trends in neurotech: devices, software and diagnostics panel
  • Investor roundtable
  • Alexander Breidenbach, director, global business development, F. Hoffmann-La Roche
  • Ana Maiques, CEO, Neuroelectrics
  • Beth Jacobs, managing partner, Excellentia Global Partners
  • Beth Shafer, head of neuroscience business development, Takeda Pharmaceutical Company
  • Bill Ketelbey, CEO and managing director, Actinogen Medical
  • Carlos Buesa, founder and CEO, Oryzon Genomics
  • Casey Lynch, co-founder, chairman and CEO, Cortexyme

See the full list here.

Edison clients presenting at the event

Actinogen Medical AOryzon Genomics
Actinogen Medical Oryzon Genomics

 

See all presenting companies

Summary

Event: 3rd Annual Neuroscience Innovation Forum
Date: 12 January, 2020
Location: Marines’ Memorial Club, San Francisco, US
Hosted by: Sachs Associates
About: The 3rd Annual Neuroscience Innovation Forum will cover biopartnering for central nervous system disorders, with industry keynotes and panels on Alzheimer’s disease, Parkinson’s disease, neuropsychiatry and pain management. There are also panels on innovation in neurotech covering banking, devices, diagnostics and software.

For more information and to register your interest, email the Sachs team.

Share this with friends and colleagues